RecruitingNCT07247773
Turkish Adaptation of the CSQ-VR
Turkish Validity and Reliability of CyberSickness in Virtual Reality Questionnaire
Sponsor
Abant Izzet Baysal University
Enrollment
42 participants
Start Date
Dec 15, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The Cybersickness in Virtual Reality Questionnaire (CSQ-VR) is a tool designed to measure the presence and intensity of cybersickness symptoms experienced in VR. The CSQ-VR is an adapted and improved version of the Cybersickness section of the Virtual Reality Neuroscience Questionnaire (VRNQ). The aim of this study is to examine the validity and reliability of the Turkish version of the CSQ-VR.
Eligibility
Min Age: 18 YearsMax Age: 30 Years
Inclusion Criteria2
- Voluntary agreement to participate in the study
- Ability to stand and walk independently
Exclusion Criteria2
- Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision
- Failure on the butterfly test of the Titmus stereotest
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07247773
Related Trials
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
NCT034070791 location
Neurobiology of Suicide
NCT025439831 location
Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms
NCT064840751 location
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
NCT0648130634 locations
Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
NCT000246351 location